[In vitro activity of Septivon-Lavril toward mycoplasma pathogenic to humans].
Septivon-Lavril is bactericidal in vitro towards species of mycoplasmas responsible for vaginal infections and their complications (U. urealyticum and M. hominis) and for the Stevens-Johnson syndrome (M. pneumoniae). As the active doses are inferior to those recommended for external use, this product, Trichlorocarbanilide, presents a clinical interest.